Review



serum vegf r3  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 86

    Structured Review

    Thermo Fisher serum vegf r3
    Comparison of the studied factors in patients with neuroendocrine tumours (NET) and healthy controls.
    Serum Vegf R3, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/serum vegf r3/product/Thermo Fisher
    Average 86 stars, based on 1 article reviews
    serum vegf r3 - by Bioz Stars, 2026-03
    86/100 stars

    Images

    1) Product Images from "Association between Biomarkers (VEGF-R2, VEGF-R3, VCAM-1) and Treatment Duration in Patients with Neuroendocrine Tumors Receiving Therapy with First-Generation Somatostatin Analogues"

    Article Title: Association between Biomarkers (VEGF-R2, VEGF-R3, VCAM-1) and Treatment Duration in Patients with Neuroendocrine Tumors Receiving Therapy with First-Generation Somatostatin Analogues

    Journal: Biomedicines

    doi: 10.3390/biomedicines11030842

    Comparison of the studied factors in patients with neuroendocrine tumours (NET) and healthy controls.
    Figure Legend Snippet: Comparison of the studied factors in patients with neuroendocrine tumours (NET) and healthy controls.

    Techniques Used: Comparison

    The Wilcoxon matched pairs test of vascular endothelial growth factor receptor 2  (VEGF-R2),  vascular endothelial growth factor  receptor 3  (VEGF-R3), and vascular cell adhesion molecule-1 (VCAM-1) for SSAs-treated NET patients.
    Figure Legend Snippet: The Wilcoxon matched pairs test of vascular endothelial growth factor receptor 2 (VEGF-R2), vascular endothelial growth factor receptor 3 (VEGF-R3), and vascular cell adhesion molecule-1 (VCAM-1) for SSAs-treated NET patients.

    Techniques Used:

    Changes in vascular endothelial growth factor receptor 2 (VEGF-R2) ( a ), vascular endothelial growth factor receptor 3 (VEGF-R3) ( b ), and vascular cell adhesion molecule-1 (VCAM-1) ( c ) levels during somatostatin analogue (SSAs) treatment in patients with neuroendocrine tumors.
    Figure Legend Snippet: Changes in vascular endothelial growth factor receptor 2 (VEGF-R2) ( a ), vascular endothelial growth factor receptor 3 (VEGF-R3) ( b ), and vascular cell adhesion molecule-1 (VCAM-1) ( c ) levels during somatostatin analogue (SSAs) treatment in patients with neuroendocrine tumors.

    Techniques Used:



    Similar Products

    86
    Thermo Fisher serum vegf r3
    Comparison of the studied factors in patients with neuroendocrine tumours (NET) and healthy controls.
    Serum Vegf R3, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/serum vegf r3/product/Thermo Fisher
    Average 86 stars, based on 1 article reviews
    serum vegf r3 - by Bioz Stars, 2026-03
    86/100 stars
      Buy from Supplier

    90
    Lonza egm-2 singlequots (hegf, hydrocortisone, fetal bovine serum, vegf, hfgf-b, r3-igf-1, ascorbic acid, ga-1000, heparin)
    Comparison of the studied factors in patients with neuroendocrine tumours (NET) and healthy controls.
    Egm 2 Singlequots (Hegf, Hydrocortisone, Fetal Bovine Serum, Vegf, Hfgf B, R3 Igf 1, Ascorbic Acid, Ga 1000, Heparin), supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/egm-2 singlequots (hegf, hydrocortisone, fetal bovine serum, vegf, hfgf-b, r3-igf-1, ascorbic acid, ga-1000, heparin)/product/Lonza
    Average 90 stars, based on 1 article reviews
    egm-2 singlequots (hegf, hydrocortisone, fetal bovine serum, vegf, hfgf-b, r3-igf-1, ascorbic acid, ga-1000, heparin) - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Lonza bovine serum, vegf, hfgf-b, r3-igf-1, ascorbic acid, ga-1000
    Comparison of the studied factors in patients with neuroendocrine tumours (NET) and healthy controls.
    Bovine Serum, Vegf, Hfgf B, R3 Igf 1, Ascorbic Acid, Ga 1000, supplied by Lonza, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bovine serum, vegf, hfgf-b, r3-igf-1, ascorbic acid, ga-1000/product/Lonza
    Average 90 stars, based on 1 article reviews
    bovine serum, vegf, hfgf-b, r3-igf-1, ascorbic acid, ga-1000 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    Comparison of the studied factors in patients with neuroendocrine tumours (NET) and healthy controls.

    Journal: Biomedicines

    Article Title: Association between Biomarkers (VEGF-R2, VEGF-R3, VCAM-1) and Treatment Duration in Patients with Neuroendocrine Tumors Receiving Therapy with First-Generation Somatostatin Analogues

    doi: 10.3390/biomedicines11030842

    Figure Lengend Snippet: Comparison of the studied factors in patients with neuroendocrine tumours (NET) and healthy controls.

    Article Snippet: Serum VEGF-R2 and VCAM-1 were determined using Quantikine ELISA, provided by R&D Systems (Minneapolis, MN, USA), and serum VEGF-R3 using Platinum ELISA, provided by Affymetrix eBioscience, according to the manufacturer’s protocol.

    Techniques: Comparison

    The Wilcoxon matched pairs test of vascular endothelial growth factor receptor 2  (VEGF-R2),  vascular endothelial growth factor  receptor 3  (VEGF-R3), and vascular cell adhesion molecule-1 (VCAM-1) for SSAs-treated NET patients.

    Journal: Biomedicines

    Article Title: Association between Biomarkers (VEGF-R2, VEGF-R3, VCAM-1) and Treatment Duration in Patients with Neuroendocrine Tumors Receiving Therapy with First-Generation Somatostatin Analogues

    doi: 10.3390/biomedicines11030842

    Figure Lengend Snippet: The Wilcoxon matched pairs test of vascular endothelial growth factor receptor 2 (VEGF-R2), vascular endothelial growth factor receptor 3 (VEGF-R3), and vascular cell adhesion molecule-1 (VCAM-1) for SSAs-treated NET patients.

    Article Snippet: Serum VEGF-R2 and VCAM-1 were determined using Quantikine ELISA, provided by R&D Systems (Minneapolis, MN, USA), and serum VEGF-R3 using Platinum ELISA, provided by Affymetrix eBioscience, according to the manufacturer’s protocol.

    Techniques:

    Changes in vascular endothelial growth factor receptor 2 (VEGF-R2) ( a ), vascular endothelial growth factor receptor 3 (VEGF-R3) ( b ), and vascular cell adhesion molecule-1 (VCAM-1) ( c ) levels during somatostatin analogue (SSAs) treatment in patients with neuroendocrine tumors.

    Journal: Biomedicines

    Article Title: Association between Biomarkers (VEGF-R2, VEGF-R3, VCAM-1) and Treatment Duration in Patients with Neuroendocrine Tumors Receiving Therapy with First-Generation Somatostatin Analogues

    doi: 10.3390/biomedicines11030842

    Figure Lengend Snippet: Changes in vascular endothelial growth factor receptor 2 (VEGF-R2) ( a ), vascular endothelial growth factor receptor 3 (VEGF-R3) ( b ), and vascular cell adhesion molecule-1 (VCAM-1) ( c ) levels during somatostatin analogue (SSAs) treatment in patients with neuroendocrine tumors.

    Article Snippet: Serum VEGF-R2 and VCAM-1 were determined using Quantikine ELISA, provided by R&D Systems (Minneapolis, MN, USA), and serum VEGF-R3 using Platinum ELISA, provided by Affymetrix eBioscience, according to the manufacturer’s protocol.

    Techniques: